J. Ragnaud

D. Breilh, J. Ragnaud, M. Dupon, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. Groupe d'Epidémilogie Clinique du SIDA en Aquitaine (GECSA).

J. Ragnaud, P. Morlat, F. Dabis, 1997, Journal of Infection.

JC virus remains latent in peripheral blood B lymphocytes but replicates actively in urine from AIDS patients.

J. Ragnaud, H. Fleury, J. Pellegrin, 1998, The Journal of infectious diseases.

Increases in CD3+CD4-CD8- T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection.

J. Ragnaud, M. Dupon, F. Dabis, 1996, The Journal of infectious diseases.

Hospital-acquired infections in patients with HIV/AIDS.

J. Ragnaud, M. Dupon, P. Morlat, 1996, The Journal of hospital infection.

HIV‐1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation

B. Masquelier, J. Ragnaud, M. Dupon, 2006, HIV medicine.

Plasma and Liver Hepatitis C Virus Variability in Patients Coinfected with Human Immunodeficiency Virus

D. Neau, J. Ragnaud, M. Dupon, 2006, Journal of Clinical Microbiology.

Human Immunodeficiency Virus Variability in Patients Coinfected with Plasma and Liver Hepatitis C Virus

D. Neau, J. Ragnaud, M. Dupon, 2006 .

Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.

V. de Lédinghen, P. Couzigou, D. Neau, 2007, Gastroenterologie clinique et biologique.

HEPATITIS B VIRUS GENOTYPES: A RETROSPECTIVE SURVEY IN SOUTHWESTERN FRANCE, 1999-2004 ETUDE RETROSPECTIVE DES GENOTYPES DU VIRUS DE L'HEPATITE B EN AQUITAINE, 1999-2004

P. Couzigou, D. Neau, J. Ragnaud, 2007 .

Hepatitis B virus genotypes : a retrospective survey in Southwestern France , 1999-2004 HÉPATITES VIRALES

J. Ragnaud, M. Dupon, F. Dabis, 2007 .

Impact of protease inhibitors on intrahepatic hepatitis C virus viral load.

D. Neau, J. Ragnaud, M. Dupon, 2001, AIDS.

Cefotaxime in the treatment of septicaemia and endocarditis.

J. Ragnaud, P. Massip, J. Aubertin, 1980, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis

J. Ragnaud, F. Demotes-mainard, G. Vinçon, 2004, European Journal of Clinical Pharmacology.

Streptococcus canis infections in humans: retrospective study of 54 patients.

D. Neau, J. Ragnaud, C. Cazorla, 2007, The Journal of infection.

[Hematologic and immunologic manifestations of primary cytomegalovirus infections in non-immunocompromised hospitalized adults].

D. Neau, J. Ragnaud, M. Dupon, 2000, La Revue de medecine interne.

[Treatment of peritonitis under continuous ambulatory peritoneal dialysis using intraperitoneal ceftazidime].

J. Ragnaud, M. Dupon, P. Morlat, 1989, Pathologie-biologie.

Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient.

D. Neau, J. Ragnaud, H. Fleury, 2000, The Journal of infection.

Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

P. Couzigou, J. Ragnaud, M. Dupon, 1996, BMJ.

CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.

M. Houghton, D. Neau, J. Ragnaud, 2002, The Journal of infectious diseases.

Intravenous cidofovir-induced iritis.

D. Neau, J. Ragnaud, M. Dupon, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003.

D. Neau, J. Ragnaud, M. Dupon, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases.

D. Neau, J. Ragnaud, F. Bonnet, 1998, Scandinavian journal of infectious diseases.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Primary coinfection with human immunodeficiency virus and cytomegalovirus presenting as acute rhabdomyolysis.

H. Gin, J. Ragnaud, P. Morlat, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virological Responses to Atazanavir–Ritonavir-Based Regimens: Resistance-Substitutions Score and Pharmacokinetic Parameters (Reyaphar Study)

D. Breilh, D. Neau, J. Ragnaud, 2005, Antiviral therapy.

J. Ragnaud, W. Rozenbaum, J. Capeau, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Acute fatal pancreatitis following treatment with pentamidine].

J. Ragnaud, M. Dupon, J. Lacut, 1986, Therapie.

Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

J. Ragnaud, M. Dupon, P. Morlat, 1992, AIDS.

Study of human herpesvirus 8 (HHV-8) variants from Kaposi's sarcoma in France: is HHV-8 subtype A responsible for more agressive tumors?

B. Masquelier, J. Ragnaud, M. Dupon, 1998, The Journal of infectious diseases.

An imported case of canine rabies in Aquitaine: investigation and management of the contacts at risk, August 2004-March 2005.

I. Capek, L. Filleul, D. Neau, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

An enlarged subpopulation of T lymphocytes bearing two distinct γδ TCR in an HIV-positive patient

J. Ragnaud, M. Bonneville, J. Déchanet, 1999 .

Cold Bone Defect on Granulocytes Labelled with Technetium-99m-HMPAO Scintigraphy: Significance and Usefulness for Diagnosis and Follow-up of Osteoarticular Infections

D. Neau, J. Ragnaud, M. Dupon, 2004, Scandinavian journal of infectious diseases.

Recurrent aseptic purulent meningitis in a patient with relapsing polychondritis.

H. Gin, J. Ragnaud, P. Morlat, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An enlarged subpopulation of T lymphocytes bearing two distinct gammadelta TCR in an HIV-positive patient.

J. Ragnaud, M. Bonneville, J. Déchanet, 1999, International Immunology.

Analysis of HIV-1 expression in vivo with in situ hybridization and the polymerase chain reaction.

J. Ragnaud, H. Fleury, J. Seigneurin, 1992, Molecular and cellular probes.

Hepatitis C virus (HCV) protease variability and anti‐HCV protease inhibitor resistance in HIV/HCV‐coinfected patients

D. Neau, J. Ragnaud, M. Dupon, 2011, HIV Medicine.

An imported case of canine rabies in Aquitaine: Investigation and management of the contacts at risk, August 2004-March 2005.

I. Capek, L. Filleul, D. Neau, 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Rhabdomyolysis and group B streptococcus meningitis in an elderly patient with hairy cell leukemia.

J. Ragnaud, J. Constans, S. Sire, 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Course of specific T lymphocyte cytotoxicity, plasma and cellular viral loads, and neutralizing antibody titers in 17 recently seroconverted HIV type 1-infected patients.

D. Neau, J. Ragnaud, M. Dupon, 1997, AIDS research and human retroviruses.

Predictive value of provirus load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy.

J. Ragnaud, M. Dupon, H. Fleury, 2003, The Journal of infectious diseases.

Intermittent antiretroviral therapy in patients with controlled HIV infection.

J. Ragnaud, J. Izopet, J. Molina, 2007, AIDS.

[Epidemiological, clinical, biological and developmental aspects of leptospirosis: apropos of 30 cases in Aquitaine].

J. Ragnaud, P. Morlat, J. Aubertin, 1994, La Revue de medecine interne.

Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?

A. Fischer, R. Tubiana, L. Cravello, 2020, The Journal of antimicrobial chemotherapy.

Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.

B. Masquelier, D. Neau, J. Ragnaud, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

IgM cryoglobulin deposits in the peripheral nerve

J. Ragnaud, A. Vital, C. Vital, 2005, Virchows Archiv A.

Drug–drug interactions with systemic antifungals in clinical practice

J. Ragnaud, M. Dupon, R. Valentino, 2007, Pharmacoepidemiology and drug safety.

Short-Term Effect of Red Wine (Consumed During Meals) on Insulin Requirement and Glucose Tolerance in Diabetic Patients

H Gin, H. Gin, J. Ragnaud, 1992, Diabetes Care.

Rhabdomyolysis and Salmonella enteritidis Infection

D. Neau, J. Ragnaud, M. E. El Kadiri, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement

S. Lawson-Ayayi, V. Lavignolle, J. Ragnaud, 2002, Annals of medicine.

Nail pigmentation associated with zidovudine.

J. Ragnaud, M. Dupon, J. Lacut, 1989, Scandinavian journal of infectious diseases.

Clinical and laboratory findings of cytomegalovirus infection in 115 hospitalized non-immunocompromised adults.

D. Neau, J. Ragnaud, M. Dupon, 2001, Annales de medecine interne.

[Peritoneal complications during continuous ambulatory peritoneal dialysis: surgical aspects].

J. Ragnaud, D. Midy, J. Baste, 1985, Journal de chirurgie.

Intraperitoneal injection of technetium-99m sulfur colloid in visualization of a peritoneo-vaginalis connection.

D. Ducassou, J. Ragnaud, L. Vuillemin, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Letters to the Editor

J. Ragnaud, P. Morlat, J. Beylot, 1998 .

[Recurrent peritonitis caused by Stomatococcus mucilanoginosus in a patient treated with continuous ambulatory peritoneal dialysis].

J. Ragnaud, C. Wone, C. Marceau, 1985, Presse medicale.

Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort.

J. Ragnaud, M. Dupon, F. Dabis, 2007, AIDS patient care and STDs.

Tuberculosis in patients infected with human immunodeficiency virus 1. A retrospective multicentre study of 123 cases in France. The Groupe des Infectiologues du Sud de la France.

J. Ragnaud, M. Dupon, 1992, The Quarterly journal of medicine.

Neuro-Muscular Biopsy in Churg-Strauss Syndrome: 24 Cases

J. Ragnaud, J. Viallard, A. Vital, 2006, Journal of neuropathology and experimental neurology.

Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.

D. Neau, J. Ragnaud, M. Dupon, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Women and HIV infection: a cohort study of 483 HIV‐infected women in Bordeaux, France, 1985–1991

J. Ragnaud, M. Dupon, P. Morlat, 1992 .

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability

J. Ragnaud, F. Raffi, C. Protopopescu, 2012, AIDS care.

Prevalence and Predictors of Deterioration of a Trustful Patient-Provider Relationship Among HIV-Infected Persons Treated With Antiretroviral Therapy

J. Ragnaud, F. Raffi, M. Carrieri, 2008, Journal of acquired immune deficiency syndromes.

Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.

D. Breilh, D. Neau, J. Ragnaud, 2009, Journal of acquired immune deficiency syndromes.

Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial.

J. Ragnaud, H. Fleury, B. Hoen, 1999, The Journal of infectious diseases.

Intrahepatic HCV RNA loads in 37 HIV‐HCV co‐infected patients with controlled HIV infection

D. Neau, J. Ragnaud, M. Dupon, 2002, Journal of medical virology.

Th1 (IL‐2, interferon‐gamma (IFN‐γ)) and Th2 (IL‐10, IL‐4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)

J. Ragnaud, J. Moreau, J. Viallard, 1999, Clinical and experimental immunology.

Circulating autoantibodies directed against conjugated fatty acids in sera of HIV‐1‐infected patients

M. Geffard, J. Ragnaud, A. Amara, 1994, Clinical and experimental immunology.

Campylobacter fetus infection. A study of four new cases.

J. Ragnaud, J. Aubertin, Lacut Jy, 1979 .

Pharmacokinetics of Intravenous and Intraperitoneal Ceftazidime in Chronic Ambulatory Peritoneal Dialysis

J. Ragnaud, P. Morlat, B. Bannwarth, 1993, Journal of clinical pharmacology.

Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis

J. Ragnaud, F. Demotes-mainard, G. Vinçon, 2004, European Journal of Clinical Pharmacology.

Herpes Zoster and Human Immunodeficiency Virus Infection: A Cohort Study of 101 Coinfected Patients

J. Ragnaud, M. Dupon, F. Dabis, 1993 .

[Clinical, microbiological, and therapeutic aspects of Nocardia sp. infections in the Bordeaux hospital from 1993 to 2003].

D. Neau, J. Ragnaud, C. Bébéar, 2006, Medecine et maladies infectieuses.